Hao Su

机构：Hebei Agricultural University, Chinese University of Hong Kong, City University of Hong Kong, Shenzhen Research Institute, Hanzhong Central Hospital, University of Hong Kong · ORCID：0000-0002-7621-8730

发表论文 217 篇 · 总被引 3594 次 · h-index 30

代表论文

• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 77)
• Near‐Unity Intersystem Crossing Efficiency and Bright Polymer Phosphorescence Enabled by Charge‐Transfer Diarylketones (2025 · Angewandte Chemie International Edition · 被引 9)
• Maternal per- and polyfluoroalkyl substance concentrations and placental DNA methylation of thyroid hormone-related genes (2025 · Journal of Hazardous Materials · 被引 8)
• Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer (2025 · Nature Communications · 被引 6)
• RNA m 1 A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target (2025 · 癌症：英文版 · 被引 5)
• Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study (2025 · HepatoBiliary Surgery and Nutrition · 被引 4)